Viral complications Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation
|
|
- Prudence Moody
- 6 years ago
- Views:
Transcription
1 (21) 27, Nature Publishing Group All rights reserved /1 $15. Viral complications Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation H Miyoshi 1, K Tanaka-Taya 1, J Hara 1, H Fujisaki 1, Y Matsuda 1, H Ohta 1, Y Osugi 1, S Okada 1 and K Yamanishi 2 Departments of 1 Developmental Medicine D-5 and 2 Microbiology C-1, Osaka University, Graduate School of Medicine, Suita, Japan Summary: Human herpesvirus-6 (HHV-6) and -7 were analyzed in 25 and 18 patients with allogeneic (allo) and autologous (auto) stem cell transplantation (SCT), respectively, by weekly examination of viral DNA in peripheral mononuclear cells using semiquantitative PCR and serologic tests up to 12 weeks after SCT. HHV-6 DNA was detected in 29.6% and 27.9% of samples after allo- and auto-sct, respectively. The proportions of HHV-6- DNA-positive samples increased in week 3 and 4 after allo-sct, and in week 1 to 3 after auto-sct. The frequency of HHV-7 DNA detection, however, was higher after auto-sct (24.7%) than allo-sct (12.8%) (P.1). Antibody titer elevation was accompanied by HHV-6 infection in eight of 1 patients. That for HHV- 7 was also frequently observed, but not associated with infection in the majority of patients. Five of six patients with 1 2 copies of HHV-6 DNA (/1 5 cells) on two consecutive occasions were allo-sct recipients and three showed clinical episodes. Conversely, three of five patients with continuous reactivation of HHV-7 were auto-sct recipients. Thus, the frequencies of HHV-6 and -7 DNA detection showed an inverse relationship comparing allo- and auto-sct, suggesting a different mechanism may regulate HHV-6 and -7 reactivation. (21) 27, Keywords: HHV-6; HHV-7; stem cell transplantation; PCR; serology Human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7) belong to -herpesvirus subfamily. HHV-6 was first isolated from patients with immunodeficiency 1 and HHV-7 was isolated from a healthy adult. 2 It is now believed that HHV-6 and HHV-7 are causative agents of exanthem subitum and febrile illnesses in children. 3,4 HHV- 6 infects persistently or latently after the primary infection in salivary glands, lymph nodes, T cells, monocytes/ Correspondence: Dr J Hara, Department of Developmental Medicine D- 5, Osaka University, Graduate School of Medical Science, 2 2 Yamadaoka, Suita, Osaka, , Japan Received 4 April 2; accepted 13 February 21 macrophages, the liver and kidney. 5,6 HHV-6 infection has some association with chronic fatigue syndrome, 7 multiple sclerosis, 8,9 hepatitis, 1 meningoencephalitis, thrombocytopenia, and hemophagocytic syndrome. 5,7 HHV- 7 also infects in infancy or early childhood and infects persistently throughout life. Although HHV-7 was shown to be CD4 + T cell tropic, 2 the cellular localization and its clinical importance have yet to be fully clarified. It is known that HHV-6 is reactivated or reinfective after stem cell transplantation (SCT) and often causes clinically significant diseases including interstitial pneumonitis, delay of engraftment, thrombotic microangiopathy and skin rash. 5,12,16 26 Thus, it appears that HHV-6 is frequently reactivated under immunosuppressive conditions following SCT and plays significant pathologic roles. On the other hand, the behavior of HHV-7 after SCT and its pathogenic roles are still obscure. 23 In this study, we analyzed the behavior of HHV-6 and HHV-7 after allogeneic (allo) and autologous (auto) SCT by examining viral DNA using semiquantitative PCR and serologic tests. Patients and methods Patients Twenty-five and 18 patients with allo- and auto-sct, respectively, were analyzed. Stem cell source was bone marrow in all patients with allo-sct and nine with auto- SCT. The remaining nine patients received autologous peripheral blood stem cell transplantation. Patient characteristics are shown in Table 1. A combination of cyclosporine and methotrexate or methotrexate alone was administered for prophylaxis against graft-versus-host disease (GVHD). Gammaglobulin 2 mg/kg intravenously was administered weekly until discharge. Oral acyclovir (5 mg/m 2 in two divided doses) was administered until discharge for prophylaxis against herpes simplex and herpes zoster viruses. When cytomegalovirus (CMV) infection was suspected based on clinical symptoms, measurement of antibody titer, detection of CMV DNA by polymerase chain reaction (PCR) and isolation of virus were attempted. Informed consent was obtained from patients and/or their parents.
2 166 Table 1 Characteristics of the patients Allogeneic SCT 25 Age (mean) (years) 9.6 (range 1 19) Sex (M:F) 13/12 Diagnosis Leukemia 21 Aplastic anemia 2 Metabolic disease 14 Donors Matched related 14 Matched unrelated 8 Mismatched (unmodified) 3 Conditioning regimen ATG 8 TBI 18 Non-TBI 7 Cyclosporine and methotrexate 21 Methotrexate 4 Acute GVHD None 9 Grade I and II 11 Grade III and IV 4 Not determined 1 Chronic GVHD No 11 Yes 1 Not determined 5 Autologous SCT 18 Age (mean) (years) 5.7 (range 1 16) Sex (M:F) 11/7 Diagnosis Leukemia 1 Solid tumor 17 Samples EDTA blood samples were collected weekly from 2 weeks before and up to 12 weeks after SCT. Altogether, 257 and 19 samples from patients with allo- or auto-sct, respectively, were collected. Mononuclear cells (MNCs) in these samples were assayed for HHV-6 and -7 DNA. Plasma samples collected up to 8 weeks after SCT from 16 patients were assayed for specific antibodies. Serologic studies Specific antibodies to HHV-6 and -7 were determined in 16 patients by an immunofluorescence antibody (IFA) test as described previously. 4,27,28 Serial two-fold dilutions of sera were put on spotted slides on which MNCs infected with HHV-6 (HST strain) or HHV-7 (7-KHR strain) were fixed with cold acetone for 2 min, and goat antibody to human IgG labeled with fluorescein-isothiocyanate (DAKO, Copenhagen, Denmark) was used as a second antibody. Monoclonal antibodies specific to HHV-6 (OHV-1 and -3) 29 and HHV-7 (KR4; unpublished data) were used to identify the virus. 3,4,29 An IFA test confirmed that these antibodies did not react with antigens of other human herpesviruses. DNA analysis PCR for HHV-6 and -7 has been described previously 27,28 and was used with some modifications as follows. The sequences of the outer primers of HHV-6 were: 5 - TTCTCCAGATGTGCCAGGGAAATCC-3 5 -CATCA TTGTTATCGCTTTCACTCTC-3 ; and the inner primers were: 5 -AGTGACAGATCTGGGCGGGCCCTAATAAC TT-3 5 -AGGTGCTGAGTGATCAGTTTCATAACCA AA-3. Those of the outer primers of HHV-7 were: 5 - AGTTCCAGCACTGCAATCG-3 5 -CCAAAAGCGTC GCTATCAA-3 ; and the inner primers were 5 -CGCATA- CACCAACCCTACTG-3 5 -GACTCATTATGGGGAT CGAC-3. The DNA thermal cycler conditions of HHV-6 consisted of a 1-min denaturation step at 94 C, a 2-min annealing step at 62 C, and elongation steps of 3, 4 and 5 min at 72 C for 1 cycles. Conditions for HHV-7 consisted of a 1-min denaturation step at 94 C, a 2-min annealing step at 55 C and a 1-min elongation step at 72 C for 3 cycles. Amplified samples were separated by electrophoresis on 2% agarose gel and were visualized with ethidium bromide staining. To confirm the results of PCR amplification, Southern hybridization with the alkaline-phosphate-conjugated oligonucleotide probes for HHV-6, variant-a and variant-b, and HHV-7 was performed. The sequences were as follows: HHV-6 variant-a, 5 -TAAATCCATTACTGGCCTTGAA- 3 ; HHV-6 variant-b, 5 -AACTCCATCAGCGGCCTCC AG-3 ; HHV-7, 5 -CATTACTCCAGTGACTTCCGATAT- TAATTT-3. The number of copies of viral genome per 1 5 MNCs was estimated based on the semiquantitative PCR as previously described 27 and expressed as follows: (1+), 1 1 copies; (2+), copies; (3+), copies; and (4+), 1 3 copies. Statistics Differences in frequencies of variables were compared with the 2 -test and Fisher s test. Differences were considered as significant for P.5. Results Viral DNA detection During the study period after SCT, HHV-6 DNA was detected in 66/223 samples (29.6%) after allo-sct and 43/154 samples (27.9%) after auto-sct. The strain detected was variant-b; no variant-a was found in any samples. HHV-6 DNA at a high level ( 1 2 copies per 1 5 cells (3+ or 4+)) was detected in 2/223 samples (9.%) after allo-sct and 12/154 samples (7.8%) after auto-sct. HHV-6 DNA was detected in 68% and in 61% analyzed patients after allo- and auto-sct, respectively. After allo- SCT, the proportions of HHV-6-DNA-positive samples increased to around % in week 3 and 4 after SCT and increased again in week 8 11 (Figure 1). After auto-sct, the frequency of HHV-6 DNA detection increased in weeks 1 to 3, earlier than after allo-sct, and decreased thereafter. The detection of more than 1 2 copies per 1 5 cells was sporadic after week 8 (Figure 1). HHV-7 DNA was detected in 27/211 samples (12.8%)
3 Allo Allo 167 % % 2 Week after SCT Sample number Auto % 2 Week after SCT Sample number Auto 2 % 2 Week after SCT Sample number Figure 1 Frequency of HHV-6 DNA detection and the copy number of viral genome in mononuclear cells from allo- and auto-sct recipients., 1 1 copies (1+);, copies (2+);, copies (3+); and +, 1 3 copies (4+) of HHV-6 genome, respectively. Week after SCT Sample number Figure 2 Frequency of HHV-7 DNA detection and the copy number of viral genome in mononuclear cells from allo- and auto-sct recipients., 1 1 copies (1+);, copies (2+);, copies (3+); and +, 1 3 copies (4+) of HHV-7 genome, respectively. after allo-sct and 36/146 samples (24.7%) after auto-sct (P.1). The samples containing more than 1 2 copies per 1 5 cells were 13/211 (6.2%) and 21/146 (13.4%) after allo- and auto-sct, respectively (P.5). However, the proportion of patients with HHV-7 DNA detection was not different after allo- and auto-sct (42% vs 67%, NS). Thus, the detection of HHV-7 DNA was significantly more frequent after auto-sct than after allo-sct, and a high copy number of HHV-7 DNA was rarely observed after allo- SCT (Figure 2). Although the frequencies of HHV-6 and HHV-7 DNA detection were not different after auto-sct, the frequency of HHV-7 DNA detection was significantly lower than that of HHV-6 after allo-sct (P.1). In addition, HHV-7 DNA was detected earlier following auto- SCT than after allo-sct (Figure 2). Association between HHV-6 and HHV-7 antibody titers and viral reactivation These data are shown in Table 2. All 12 patients analyzed before SCT were seropositive for HHV-6 and -7. Among 16 patients analyzed, 1 patients showed a significant increase of HHV-6 antibody titers and the timing of the titer increase was close to that of virus reactivation in eight of these patients. The remaining six patients showed no increase of either HHV-6 antibody titer or infection throughout the study period. HHV-7 antibody titers increased in 13 patients after transplantation, but no apparent correlation with detection of HHV-7 was observed in the most of them. No HHV-7 infection was observed in six of the 13 patients with an increase of antibody titer and in two of the three without an increase in antibody titer. Administration of intravenous gammaglobulin did not appear to influence infection. Clinical symptoms associated with HHV-6 and -7 reactivation There appeared to be no significant relationships between the reactivation of HHV-6 and -7, and the use of antithymocyte globulin and total body irradiation or the degree of GVHD. Six and five patients showed reactivation of HHV- 6 or -7 at a high level (3+ or 4+) on two consecutive occasions, respectively (Table 3). Five of the six patients with reactivation of HHV-6 and two of the five with HHV- 7 reactivation were recipients of allo-sct. In three of six patients with HHV-6 reactivation, in addition to fever, persistent thrombocytopenia, generalized skin rash similar to that observed with exanthem subitum and interstitial pneumonitis were observed coincident with the increase of HHV-6 copy numbers. In all patients, no other pathogens including HHV-7 and CMV were detected. In patient UPN 115, HHV-6 DNA was detected at a high copy number from BM cells, as well as PBMCs. In patient UPN 118, HHV-6 DNA was detected from bronchoalveolar lavage specimens. In patient UPN 133, symptoms developed before engraftment and HHV-6 was isolated from PBMCs on day 12. Patients UPN 118 and 133 received administration of ganciclovir and both showed an improvement of symptoms. However, patient UPN 118 died of multi-organ failure after resolution of pneumonitis. In the remaining three patients and other patients with reactivation of HHV-6 at a lower level, no specific symptoms developed. Persistent thrombocytopenia accompanied with fever and interstitial pneumonitis were observed in other patients. However, no
4 168 Table 2 Patients with significant serologic HHV-6 and/or HHV-7 increase UPN Age Donor HLA HHV-6 a HHV-7 a (years)/sex Time of Time of DNA Time of Time of DNA serologic detection serologic detection increase increase 125 8/M Sibling Matched 5 5 (4+) 4 4 (2+) /M Sibling Matched 2 2 (2+) /M Sibling Matched 4 4 (2+) 4 8 (2+) 133 8/M Sibling Matched 3 2 (3+) /M Unrelated Matched 5 4 (2+) 7 5 (2+) /F Unrelated Mismatched (1-locus) /M Mother Mismatched (2-loci) /F Mother Mismatched (2-loci) /F Auto 2 3 (2+) 2 4 (2+) 2 1/M Auto 2 1 (2+) 2 4 (2+) 262 7/M Auto 2 2 (2+) 2 1 (2+) 263 5/M Auto /M Auto 4 7 (2+) 4 8 (2+) a Numbers indicate the weeks from transplantation. Numbers in parentheses indicate the number of copies of viral DNA. Table 3 Patients with viral DNA at a high copy number UPN Age Donor HLA Acute Weeks after SCT a Associated symptom and diseases (years)/sex GVHD HHV-6 DNA /F Sibling Matched II thrombocytopenia, fever (week 6 1) 125 8/F Sibling Matched I /M Sibling Matched eruption, fever (week 2 3) 9 12/F Father Matched II /F Father Mismatched IV 4 4 interstitial pneumonitis (week 3 4) (1-locus) 2 1/M Auto HHV-7 DNA 125 8/F Sibling Matched I /M Sibling Matched I /M Auto /F Auto /F Auto a Numbers indicate the numbers of copies of viral DNA on a semiquantitative scale from to 4. difference of the frequency of fever and skin rash was observed between patients with and without HHV-6 reactivation, since these symptoms are frequently observed after SCT and caused by GVHD, bacterial and fungal infections as well as HHV-6 infection. In five patients with HHV-7 reactivation, no symptoms associated with the increase of HHV-7 copy number were documented. Thus, in contrast to HHV-7, continuous reactivation of HHV-6 was more often found in allo-sct and frequently was associated with clinical symptoms. Discussion We studied HHV-6 and -7 infection after SCT using semiquantitative PCR and serologic tests and examined the relationship to clinical symptoms. HHV-6 DNA was detected in 68% and 61% of patients in allo- and auto-sct, respectively. These frequencies are similar to those reported by others. 5,21 23 Although the proportions of HHV-6-DNApositive samples were similar between in allo- and auto- SCT, the high frequency of the detection of HHV-6 DNA persisted during the study period in allo-sct in contrast to auto-sct where the increase of the frequency was sporadic. In addition, five of six patients with continuous reactivation of HHV-6 at a high level were after allo-sct and clinical symptoms seemingly attributed to HHV-6 infection were observed in three of these patients. This difference in alloand auto-sct seems to be attributable to the intense immune suppression caused by the more intense pre-conditioning regimen, GVHD and immune suppressive agents in allo-sct allowing reactivation of HHV-6. Although stem cell source was peripheral blood in half of patients with auto-sct, no difference was observed in the fre-
5 quency of viral reactivation between patients with bone marrow and peripheral blood. On the other hand, the frequency and time of the detection of HHV-7 DNA were quite different from those of HHV-6. After allo-sct, the initiation of the HHV-7 DNA detection was later than that of HHV-6 and the frequency was lower. HHV-7 DNA was detected in 42% of patients similar to a previous report. 23 Based on the semiquantitative analysis, patients with high numbers of viral copies (3+ or 4+) were rare. Conversely, after auto-sct, the frequency of the HHV-7 DNA detection was higher, ie HHV-7 DNA was detected in 67% of patients (36/146 samples), and HHV-7 DNA was detected at earlier times than after allo- SCT. In addition, three of five patients with continuous reactivation of HHV-7 at a high level were after auto-sct and no clinical symptoms associated with HHV-7 infection were observed. Since HHV-7 DNA was detected in almost all healthy individuals, 27 it appears that replication of HHV- 7 in MNCs was suppressed, especially in allo-sct. Thus, the presence of HHV-7 was not associated with intense immunosuppression and more intense immune suppression seemed to eliminate HHV-7, suggesting that mechanisms regulating reactivation and/or maintenance of HHV-7 may be different from HHV-6. Indeed, HHV-7 is isolated from CD4 + T cells after phytohemagglutinin stimulation, 2 indicating that T cell activation is required for reactivation of HHV-7. Elucidation of the mechanisms explaining the converse relationship between HHV-6 and -7 reactivation awaits further study. Antibody titers for HHV-6 increased in 1 of 16 patients analyzed and these serologic increases were associated with HHV-6 infection in eight patients, indicating that antibody response to HHV-6 was maintained in a majority of SCT recipients and serologic tests are useful for the diagnosis HHV-6 infection. Although gammaglobulin was administered weekly at a dosage of 2 mg/kg intravenously until discharge, antibody titers to HHV-6 increase only twofold after administration of 2 g/kg of gammaglobulin for Kawasaki disease (unpublished observation). Antibody titers for HHV-7 increased in 13 patients without an apparent association with HHV-7 infection. Although this discrepancy can not be easily explained, one possible explanation is that HHV-7 might reactivate mainly in cells other than blood cells and cellular tropism might be different from that of HHV-6 after SCT. Although HHV-7 was shown to be present in CD4 + T cells, 3 cellular tropism needs to be fully clarified for a better understanding of HHV-7 behavior. In this study, we recognized three patients who had some HHV-6-associated clinical findings after allo-sct. Interstitial pneumonitis developed in two patients. In one of them, the onset, accompanied by skin rash similar to that observed at exanthem subitum, was very early after transplantation and before engraftment. Thus, when early onset of skin rash with a elevation of body temperature is observed, HHV-6 infection should be considered. In patient UPN 115, since persistent low-grade fever and thrombocytopenia were associated with HHV-6 infection and these symptoms were relieved with the disappearance of HHV-6 DNA, it is suggested that this clinical episode was caused by HHV-6 infection. In summary, HHV-6 and -7 DNA was frequently detected in allo- and auto-sct recipients. In some allo-sct recipients who showed HHV-6 reactivation at a high copy number, clinical symptoms associated with HHV-6 were documented. Thus, diseases associated with HHV-6 infection were more frequent than had been thought and semiquantitative PCR analysis, together with serologic tests, has a clinical value for the diagnosis of HHV-6 infection. However, the relationship between HHV-7 reactivation and clinical episodes was not clear. A more detailed study will help our further understanding of pathogenic roles of HHV-7, not only in immunocompromised hosts, but also in the healthy population. Acknowledgements This study was supported in part by a Grant-in Aid from the Ministry of Education, Science and Culture of Japan. We thank T Aono of Toyobo Chemical Co. for the synthesis of DNA primers and probes. References 1 Salahuddin SZ, Ablashi DV, Markham PD et al. Isolation of a new virus, HBLV in patients with lymphoproliferative disorders. Science 1986; 234: Frenkel N, Schirmer EC, Wyatt LS et al. Isolation of a new herpesvirus from CD4 + T cells. Proc Natl Acad Sci USA 199; 87: Yamanishi K, Okuno T, Shiraki K et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: Tanaka K, Kondo T, Torigoe S et al. Human herpesvirus-7: another causal agent for roseola (exanthem subitum). J Pediatr 1994; 125: Wilborn F, Brinkmann V, Schmidt CA et al. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994; 83: Kondo K, Kondo T, Okuno T et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991; 72: Di Luca D, Dolcetti R, Mirandola P et al. Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis 1994; 17: Challoner PB, Smith KT, Parker JD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: Soldan SS, Berti R, Salem N et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997; 3: Tajiri H, Nose O, Baba K, Okada S. Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet 199; 335: Hall CB, Long CE, Schnabel KC et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. New Engl J Med 1994; 331: Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fetal encephalitis due to variant herpesvirus-6 infection in a bone marrow transplant recipient. New Engl J Med 1994; 33:
6 17 13 Ishiguro N, Yamada S, Takahashi T et al. Meningo-encephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 199; 79: Yanagihara K, Tanaka-Taya K, Itagaki K et al. Human herpesvirus 6 meningoencephalitis with sequelae. Pediatr Infect Dis J 1995; 14: Singh N, Carrigan DR, Gayowski T et al. Variant B human herpesvirus-6-associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplantation recipient. Transplantation 1995; : Drobyski WR, Dunne WM, Burd EM et al. Human herpesvirus-6 (HHV-6) infection in allogenic bone marrow transplant recipients: evidence of a marrow suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167: Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in bone marrow transplant recipient. Clin Infect Dis 1996; 22: Carrigan DR, Drobyski WR, Russler SK et al. Interstitial pneumonitis associated with herpesvirus-6 infection after marrow transplantation. Lancet 1991; 338: Asano Y, Yoshikawa T, Suga S et al. Reactivation of herpesvirus type 6 in children receiving bone marrow transplantations for leukemia. New Engl J Med 1991; 324: Drobyski WR, Eberle M, Majewski D, Baxter-Lowe LA. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol 1993; 31: Yoshikawa T, Suga S, Asano Y et al. Human herpesvirus- 6 infection in bone marrow transplantation. Blood 1991; 78: Kadakia MP, Rybka WB, Stewart JA et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996; 87: Wang F-Z, Dahl H, Linde A et al. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: Cone RW, Hackman RC, Huang M-LW et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. New Engl J Med 1993; 329: Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124: Matsuda Y, Hara J, Miyoshi H et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant 1999; 24: Tanaka-Taya K, Kondo T, Mukai T et al. Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. JMedVirol1996; 48: Yalcin S, Karpuzoglu T, Suleymanlar G et al. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol 1994; 136: Okuno T, Sao H, Asada H et al. Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies. Virology 199; 176: Lusso P, Secchiero P, Crowley RW et al. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci USA 1994; 94:
REVIEW ARTICLE HUMAN HERPESVIRUS 6 INFECTION IN TRANSPLANTATION
Nagoya J. Med. Sci. 64. 11 ~ 18, 2001 REVIEW ARTICLE HUMAN HERPESVIRUS 6 INFECTION IN TRANSPLANTATION TETSUSHI YOSHIKAWA Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya
More informationPrevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience
ORIGINAL ARTICLE Arch. Immunol. Ther. Exp., 2008, 56, 201 206 PL ISSN 0004-069X DOI 10.1007/s00005-008-0021-6 Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients:
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationDiagnosis of CMV infection UPDATE ECIL
UPDATE ECIL-4 2011 Recommendations for CMV and HHV-6 management in patients with hematological diseases Per Ljungman, Rafael de la Camara, Hermann Einsele, Dan Engelhard, Pierre Reusser, Jan Styczynski,
More informationPUO in the Immunocompromised Host: CMV and beyond
PUO in the Immunocompromised Host: CMV and beyond PUO in the immunocompromised host: role of viral infections Nature of host defect T cell defects Underlying disease Treatment Nature of clinical presentation
More informationINTRODUCTION. Biology of Blood and Marrow Transplantation 13: (2007) 2007 American Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation 13:100-106 (2007) 2007 American Society for Blood and Marrow Transplantation 1083-8791/07/1301-0001$32.00/0 doi:10.1016/j.bbmt.2006.09.003 Risk Factors for Developing
More informationVirological Surveillance in Paediatric HSCT Recipients
Virological Surveillance in Paediatric HSCT Recipients Dr Pamela Lee Clinical Assistant Professor Department of Paediatrics & Adolescent Medicine Queen Mary Hospital LKS Faculty of Medicine, The University
More informationFrequent Detection of the Human Herpesvirus 6-Specific Genomes in the Livers of Children with Various Liver Diseases
JOURNAL OF CLINICAL MICROBIOLOGY, June 2001, p. 2173 2177 Vol. 39, No. 6 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.6.2173 2177.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More information4. SYSTEMIC REACTIONS
HUMAN HERPES VIR US-6 25 3.3 Further Reading Krueger GRF, Koch B, Ramon A, Ablashi DV, Salahuddm SZ, Josephs SF, Streicher HZ, Gallo RC, Habermann U. Antibody prevalence to HBLV (human herpesvirus-6, HHV-6)
More informationRecommendations for VZV management in. Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman
Recommendations for VZV management in patients Cas cliniques with leukemia Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman Introduction Acute
More information5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow
5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL
More informationThe Incidence of Human Herpe svirus 6 Infection in Children wi Febrile Convulsion admitted to theuniversi Hospital Kuala L umpur
The Incidence of Human Herpe svirus 6 Infection in Children wi Febrile Convulsion admitted to theuniversi Hospital Kuala L umpur K B Chua, MRCP*, S K Lam, FRCPath*, S AbuBakar, Ph.D*, M T Koh, MRCP**,
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationClass 10. DNA viruses. I. Seminar: General properties, pathogenesis and clinial features of DNA viruses from Herpesviridae family
English Division, 6-year programme Class 10 DNA viruses I. Seminar: General properties, pathogenesis and clinial features of DNA viruses from Herpesviridae family II. Assays to be performed: 1. Paul-Bunnel-Davidsohn
More informationRelationship between pre-existing anti-varicella zoster virus ACCEPTED. (VZV) antibody and clinical VZV reactivation in hematopoietic
JCM Accepts, published online ahead of print on 11 October 2006 J. Clin. Microbiol. doi:10.1128/jcm.01312-06 Copyright 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationHuman Herpesvirus 6 DNA in Plasma after Allogeneic Stem Cell Transplantation: Incidence and Clinical Significance
MAJOR ARTICLE Human Herpesvirus 6 DNA in Plasma after Allogeneic Stem Cell Transplantation: Incidence and Clinical Significance Masao Ogata, 1 Hiroshi Kikuchi, 2 Takako Satou, 1 Rie Kawano, 1 Junji Ikewaki,
More informationOne Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases
One Day BMT Course by Thai Society of Hematology Management of Graft Failure and Relapsed Diseases Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital
More informationMedical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses
Medical Virology Lecture 2 Asst. Prof. Dr. Dalya Basil Herpesviruses, Orthomyxoviruses, and Retro virus - Herpesviruses Structure & Composition: Herpesviruses Enveloped DNA viruses. All herpesviruses have
More informationHuman herpesvirus 6 (HHV-6) was first isolated
Haematologica 2000; 85:458-463 original paper Molecular Hematology Human herpesvirus 6 in hematologic diseases in China XIAO-TONG MA*, YU-HUA SONG*, DONG-MEI LU,* GUI-FAN MU, # GE LI,* LIN-XIANG JI,* REN-CHI
More informationTrends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014
Trends in Hematopoietic Cell Transplantation AAMAC Patient Education Day Oct 2014 Objectives Review the principles behind allogeneic stem cell transplantation Outline the process of transplant, some of
More informationEarly Diagnosis of Primary Human Herpesvirus 6 Infection in Childhood: Serology, Polymerase Chain Reaction, and Virus Load
1250 Early Diagnosis of Primary Human Herpesvirus 6 Infection in Childhood: Serology, Polymerase Chain Reaction, and Virus Load Susan S. Chiu, C. Y. Cheung, Catherine Y. C. Tse, and Malik Peiris Departments
More informationApoptosis of CD4 M T lymphocytes in human herpesvirus-6 infection
Journal of General Virology (1998), 79, 143 147. Printed in Great Britain.... SHORT COMMUNICATION Apoptosis of CD4 M T lymphocytes in human herpesvirus-6 infection Masaki Yasukawa, 1 Yasuhiro Inoue, 1
More informationAdvances in gene encoding proteins of human herpesvirus 6
2009 9 4 3 Journal of Microbes and Infection, September 2009, Vol. 4, No. 3 165 6 1, 2 1., 241000; 2., 210029 : 6 ( HHV-6) DNA, HHV-6 80 100, ( IE) DNA DNA HHV-6 : 6 ; ; Advances in gene encoding proteins
More informationReduced-intensity Conditioning Transplantation
Reduced-intensity Conditioning Transplantation Current Role and Future Prospect He Huang M.D., Ph.D. Bone Marrow Transplantation Center The First Affiliated Hospital Zhejiang University School of Medicine,
More informationViral Infections. 1. Prophylaxis management of patient exposed to Chickenpox:
This document covers: 1. Chickenpox post exposure prophylaxis 2. Chickenpox treatment in immunosuppressed/on treatment patients 3. Management of immunosuppressed exposed to Measles All children with suspected
More informationHLA-DR-matched Parental Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-risk Acute Leukemia
BRIEF COMMUNICATION HLA-DR-matched Parental Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-risk Acute Leukemia Shang-Ju Wu, Ming Yao,* Jih-Luh Tang, Bo-Sheng Ko, Hwei-Fang
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationExpert Working Group on HHV-6 and 7 Laboratory Diagnosis and Testing
Canada Communicable Disease Report ISSN 1188-4169 Date of Publication: September 2000 Volume 26S4 Supplement Expert Working Group on HHV-6 and 7 Laboratory Diagnosis and Testing Our mission is to help
More informationHuman Herpes Virus-6 Limbic Encephalitis
Case Studies [1] March 19, 2013 Case history: A 32-year-old Caucasian female with newly diagnosed acute myeloid leukemia (AML) was treated with induction chemotherapy and attained complete remission. She
More informationLe infezioni fungine nel trapianto di cellule staminali emopoietiche. Claudio Viscoli Professor of Infectious Disease University of Genova, Italy
Le infezioni fungine nel trapianto di cellule staminali emopoietiche Claudio Viscoli Professor of Infectious Disease University of Genova, Italy Potential conflicts of interest Received grants as speaker/moderator
More informationAn Overview of Blood and Marrow Transplantation
An Overview of Blood and Marrow Transplantation October 24, 2009 Stephen Couban Department of Medicine Dalhousie University Objectives What are the types of blood and marrow transplantation? Who may benefit
More informationHuman herpesvirus (HHV)-6 and -7 are two of the
REVIEW ARTICLE The Impact of Human Herpesvirus-6 and -7 Infection on the Outcome of Liver Transplantation Raymund R. Razonable * and Carlos V. Paya * Human herpesvirus (HHV)-6 and -7 are novel members
More informationStem Cell Transplantation for Severe Aplastic Anemia
Number of Transplants 10/24/2011 Stem Cell Transplantation for Severe Aplastic Anemia Claudio Anasetti, MD Professor of Oncology and Medicine Chair, Blood and Marrow Transplant Dpt Moffitt Cancer Center
More informationCMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy
(2000) 26, 413 417 2000 Macmillan Publishers Ltd All rights reserved 0268 3369/00 $15.00 www.nature.com/bmt CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir
More informationSevere Viral Related Complications Following Allo-HCT for Severe Aplastic Anemia
Severe Viral Related Complications Following Allo-HCT for Severe Aplastic Anemia Liat Shragian Alon, MD Rabin Medical Center, ISRAEL #EBMT15 www.ebmt.org Patient: 25-year-old male No prior medical history
More informationLab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1
Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific
More informationResults. Clinical reports of transplant recipients
Cloning of EBV genes as fusion proteins with Renilla luciferase for Luciferase Immunoprecipitation System (LIPS) analysis A panel of 13 different EBV proteins was generated as Renilla luciferase (Ruc)
More informationMANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More informationDr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION
Benjamini. Ch. 19, Pgs 379-399 Page 1 of 10 TRANSPLANTATION I. KINDS OF GRAFTS II. RELATIONSHIPS BETWEEN DONOR AND RECIPIENT Benjamini. Ch. 19, Pgs 379-399 Page 2 of 10 II.GRAFT REJECTION IS IMMUNOLOGIC
More informationThe clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation
Bone Marrow Transplantation, (1999) 23, 45 51 1999 Stockton Press All rights reserved 0268 3369/99 $12.00 http://www.stockton-press.co.uk/bmt The clinical utility of CMV surveillance cultures and antigenemia
More informationAn Introduction to Bone Marrow Transplant
Introduction to Blood Cancers An Introduction to Bone Marrow Transplant Rushang Patel, MD, PhD, FACP Florida Hospital Medical Group S My RBC Plt Gran Polycythemia Vera Essential Thrombocythemia AML, CML,
More informationCHAPTER 3 LABORATORY PROCEDURES
CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES 3.1 HLA TYPING Molecular HLA typing will be performed for all donor cord blood units and patients in the three reference laboratories identified
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More informationPlease submit supporting medical documentation, notes and test results.
Pharmacy Prior Authorization AETA BETTER HEALTH FLORIDA Valcyte (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date.
More informationTherapeutic Advances in Treatment of Aplastic Anemia. Seiji Kojima MD. PhD.
Therapeutic Advances in Treatment of Aplastic Anemia Seiji Kojima MD. PhD. Department of Pediatrics Nagoya University Graduate School of Medicine Chairman of the Severe Aplastic Anemia Working Party Asia-Pacific
More informationRob Wynn RMCH & University of Manchester, UK. HCT in Children
Rob Wynn RMCH & University of Manchester, UK HCT in Children Summary Indications for HCT in children Donor selection for Paediatric HCT Using cords Achieving engraftment in HCT Conditioning Immune action
More informationduring primary HHV-6 infection.
62 Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan S Suga K Suzuki M Ihira T Yoshikawa Y Asano Department of Pediatrics, Showa Hospital, Konan, Aichi
More informationEvaluation of a Commercial Enzyme-Linked Immunosorbent Assay for Detection of Serum Immunoglobulin G Response to Human Herpesvirus 6
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1996, p. 675 679 Vol. 34, No. 3 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Evaluation of a Commercial Enzyme-Linked Immunosorbent Assay
More informationHuman Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU
Human Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU HERPES VIRUS INFECTIONS objectives: ØTo know the clinically important HHVs. ØTo
More informationThe role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.
The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. Robert Liwski, MD, PhD, FRCPC Medical Director HLA Typing Laboratory Department of Pathology Dalhousie
More informationMaternal oral CMV recurrence following postnatal primary infection in infants
Maternal oral CMV recurrence following postnatal primary infection in infants I. Boucoiran, B. T. Mayer, E. Krantz, S. Boppana, A. Wald, L. Corey, C.Casper, J. T. Schiffer, S. Gantt No conflict of interest
More informationHistocompatibility Evaluations for HSCT at JHMI. M. Sue Leffell, PhD. Professor of Medicine Laboratory Director
Histocompatibility Evaluations for HSCT at JHMI M. Sue Leffell, PhD Professor of Medicine Laboratory Director JHMI Patient Population Adults Peds NMDP data >20,000 HSCT JHMI HSCT Protocols Bone marrow
More informationSkin Pathway Group Alemtuzumab in Cutaneous Lymphoma
Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Indication: Treatment of patients with Cutaneous Lymphoma (Unlicensed use) Disease control prior to Reduced Intensity Conditioning Stem Cell Transplant
More informationImmunosuppressants. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Immunosuppressants Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Immunosuppressive Agents Very useful in minimizing the occurrence of exaggerated or inappropriate
More informationEBV in HSCT 2015 update of ECIL guidelines
ECIL-6 EBV in HSCT 2015 update of ECIL guidelines Jan Styczynski (Poland, chair), Walter van der Velden (Netherlands), Christopher Fox (United Kingdom), Dan Engelhard (Israel), Rafael de la Camara (Spain),
More informationSpecific Requirements
Specific Requirements AIMS Specific requirements your patients have for transfusion and how this is managed Classify which patients require: Irradiated components CMV negative components Washed components
More informationAn Immunoblot Assay for Detection of Immunoglobulin M Antibody to Human Herpesvirus 6
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2000, p. 823 827 Vol. 7, No. 5 1071-412X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. An Immunoblot Assay for
More informationAntiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
Antiviral Drugs Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Viruses Viruses are the smallest infective agents, consisting of nucleic acid (DNA or RNA) enclosed
More informationLong-Term Outcome of Human Herpesvirus-6 Encephalitis after Allogeneic Stem Cell Transplantation
Long-Term Outcome of Human Herpesvirus-6 Encephalitis after Allogeneic Stem Cell Transplantation Rika Sakai, 1 Heiwa Kanamori, 2 Kenji Motohashi, 2 Wataru Yamamoto, 1 Shiro Matsuura, 1 Atsuko Fujita, 1
More informationIl trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici
Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici Anna Locasciulli Ematologia e Trapianto di Cellule Staminali Emopoietiche Ospedale S.Camillo, Roma Il trapianto
More informationCMV in kidney Transplant recipient: A diagnostic and therapeutic Dilema
CMV in kidney Transplant recipient: A diagnostic and therapeutic Dilema By Mohamed A. Sobh MD,FACP Professor and head of Nephrology Urology and Nephrology Center Mansoura - Egypt Cytomegalovirus Virology
More informationDetection of Human Herpesvirus 6 DNA in Serum by a Microplate PCR-Hybridization Assay
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1998, p. 68 72 Vol. 36, No. 1 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Detection of Human Herpesvirus 6 DNA in Serum by a Microplate
More informationViruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae
Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,
More informationActivation of Gene Expression by Human Herpes Virus 6
Activation of Gene Expression by Human Herpes Virus 6 M. E. M. Campbell and S. McCorkindale 1 Introduction Human herpes virus type 6 (HHV-6) was first detected by Salahuddin et al. [6] and has been isolated
More informationClinical Study CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
Bone Marrow Research Volume 22, Article ID 37575, 8 pages doi:.55/22/37575 Clinical Study CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients Emilia
More informationAntiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
Antiviral Drugs Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Viruses Viruses are the smallest infective agents, consisting of nucleic acid (DNA or RNA) enclosed
More informationProperties of Herpesviruses
Herpesviruses Properties of Herpesviruses Structure and Composition Spherical icosahedron, 150-200 nm Double-stranded DNA, linear More than 35 proteins Enveloped Replication from nucleus (budding) Features
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More informationHaploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia
Haploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia Carmem Bonfim Director Pediatric Blood and Marrow Transplantation Program HC Federal
More informationAppendix E1. Epidemiology
Appendix E1 Epidemiology Viruses are the most frequent cause of human infectious diseases and are responsible for a spectrum of illnesses ranging from trivial colds to fatal immunoimpairment caused by
More informationORIGINAL ARTICLE. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients
ORIGINAL ARTICLE Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients A. Kulkarni 1, D. Westmoreland 1 and J. D. Fox 2 1 Department of Virology,
More informationClass-Specific Antibody Response in Acyclovir- Treated and Adenine Arabinoside-Treated Patients with Primary Genital Herpes Simplex Virus Infection
Microbiol. Immunol., 39(10), 795-799, 1995 Class-Specific Antibody Response in Acyclovir- Treated and Adenine Arabinoside-Treated Patients with Primary Genital Herpes Simplex Virus Infection Takashi Kawana*,1,
More informationRobert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Robert B. Colvin Transplantation: Friendly organs in a hostile environment Robert B. Colvin,
More informationBone Marrow Transplantation in Myelodysplastic Syndromes. An overview for the Myelodysplasia Support Group of Ottawa
Bone Marrow Transplantation in Myelodysplastic Syndromes An overview for the Myelodysplasia Support Group of Ottawa Objectives Provide brief review of marrow failure Re emphasize the importance of predictions
More informationHuman Herpesvirus-6 Infection After Liver Transplantation
702 Human Herpesvirus-6 Infection After Liver Transplantation Irmeli Lautenschlager, Krister Höckerstedt, Kimmo Linnavuori, and Eero Taskinen From the Department of Virology, Fourth Department of Surgery,
More informationEarly Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical Study
Early Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical Study Remy Dulery, 1 Julia Salleron, 2 Anny Dewilde, 3 Julien Rossignol, 1 Eileen M. Boyle,
More informationViral Diseases in the Hematolymphatics. By:Ass. Prof. Nader Alaridah
Viral Diseases in the Hematolymphatics By:Ass. Prof. Nader Alaridah Parvoviruses Members of the family Parvoviridae, are small (diameter, ~22 nm), nonenveloped, icosahedral viruses with a linear single-strand
More informationA Population-Based Study of Primary Human Herpesvirus 6 Infection
The new england journal of medicine original article A Population-Based Study of Primary Human Herpesvirus 6 Infection Danielle M. Zerr, M.D., M.P.H., Amalia S. Meier, Ph.D., Stacy S. Selke, M.A., Lisa
More informationDiagnosingneurotropicvirus infectionsin immunocompromised individuals
Molecular Virology Unit, Microbiology and Virology Dept IRCCS Policlinico San Matteo, Pavia DptClinical and Surgical Sciences, Diagnostics and Pediatrics University of Pavia Diagnosingneurotropicvirus
More informationPediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017
Pediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017 S. Rod Rassekh Pediatric Oncologist BC Children s Hospital Objectives Discuss the immune system and vaccination
More informationMUD SCT. Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University
MUD SCT Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University Outlines Optimal match criteria for unrelated adult donors Role of ATG in MUD-SCT Post-transplant
More informationHarrison's Internal Medicine > Chapter 175. Cytomegalovirus and Human Herpesvirus Types 6, 7, and 8 >
Page 1 of 10 Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Copyright The McGraw-Hill Companies. All rights reserved. Harrison's Internal Medicine
More informationInvestigation into withdrawal of entecavir after 20 months in an HBsAb-positive patient who received HBsAg allogeneic stem cell transplantation
Investigation into withdrawal of entecavir after 20 months in an HBsAb-positive patient who received HBsAg allogeneic stem cell transplantation J. Peng, W.F. Luo, B. Zhou and W.Q. Wen Department of Infectious
More informationFederica Galaverna, 1 Daria Pagliara, 1 Deepa Manwani, 2 Rajni Agarwal-Hashmi, 3 Melissa Aldinger, 4 Franco Locatelli 1
Administration of Rivogenlecleucel (Rivo-cel, BPX-501) Following αβ T- and B-Cell Depleted Haplo-HSCT in Children With Transfusion-Dependent Thalassemia Federica Galaverna, 1 Daria Pagliara, 1 Deepa Manwani,
More informationTime Course and Frequency of Epstein-Barr Virus Reactivation after Kidney Transplantation: Linkage to Renal Allograft Rejection
BRIEF REPORT Time Course and Frequency of Epstein-Barr Virus Reactivation after Kidney Transplantation: Linkage to Renal Allograft Rejection Wolfram J. Jabs, 1 Susanne Maurmann, 1 Hans-J. Wagner, 2 Michael
More informationTransplantation Immunology Booklet C
Booklet C Pretest Correct Answers 3. (C) is correct. One of the major barriers to successful hematopoietic stem cell transplantation is the antigens coded for by the major histocompatibility gene complex.
More informationVZV, EBV, and HHV-6-8
VZV, EBV, and HHV-6-8 Anne Gershon Common Features of Herpesviruses Morphology Basic mode of replication Primary infection followed by latency Ubiquitous Ability to cause recurrent infections (reactivation
More informationGeneral Terms: Appendix B. National Marrow Donor Program and The Medical College of Wisconsin
Glossary of Terms This appendix is divided into two sections. The first section, General Terms, defines terms used throughout the CIBMTR data collection forms. The second section, FormsNet TM 2 Terms,
More informationRevista Cubana de Hematología, Inmunología y Hemoterapia. 2017; 36 (Suplemento).
Depletion of TCR alpha/beta+ T-lymphocytes from grafts for haplo haematopoietic CELL transplantation (HCT) in children Heilmann C, Ifversen M, Haastrup E, Fischer-Nielsen A. Haematopoietic Cell Transplantation
More informationApproach to the Transplant Patient. Amy Musiek, MD AAD Annual Meeting 2018
Approach to the Transplant Patient Amy Musiek, MD AAD Annual Meeting 2018 Disclosures Actelion: speaker, advisory board, investigator Elorac: investigator Kyowa: investigator, advisory board Seattle genetics:
More informationTranspla. antation. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences
Viral Mo olecular Diagno osis in Transpla antation Seyed Alireza Nadji, Ph.D. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences Which techniques
More informationMultiple Choice Questions - Paper 1
Multiple Choice Questions - Paper 1 Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could
More informationDetection of Cytomegalovirus, Epstein-Barr Virus and Human Herpes Virus 6 and 7 DNA in Febrile Children with Cancer
Human Journals Research Article December 2016 Vol.:5, Issue:2 All rights are reserved by Daniel Thome Catalan et al. Detection of Cytomegalovirus, Epstein-Barr Virus and Human Herpes Virus 6 and 7 DNA
More informationTransferred Herpes Simplex Virus Immunity after Stem-Cell Transplantation: Clinical Implications
MAJOR ARTICLE Transferred Herpes Simplex Virus Immunity after Stem-Cell Transplantation: Clinical Implications W. Garrett Nichols, 1,3 Michael Boeckh, 1,3 Rachel A. Carter, 1,2 Anna Wald, 3,4,5 and Lawrence
More informationHuman Herpesviruses. Medical Virology, 27 Nov 2015.
Human Herpesviruses Assoc.Prof. Murat Sayan Kocaeli Üniversitesi, Rutin PCR Lab. Sorumlu Öğt.Üyesi Yakın Doğu Üniversitesi, DESAM Kurucu Öğrt. Üyesi sayanmurat@hotmail.com 0533 6479020 Medical Virology,
More information4100: Cellular Therapy Essential Data Follow-Up Form
4100: Cellular Therapy Essential Data Follow-Up Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: Visit: 100 day 6 months 1 year 2 years >2 years, Specify:
More informationEpstein-Barr Virus 1
Epstein-Barr Virus 1 Herpesviruses dsdna, linear, enveloped, 180-200 nm Large genome, codes for 75 viral proteins 50-70% similarity Cross reactivity between HSV and VZV HSV-2 virus particle. Note that
More informationPersistent Infections
Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent
More information2017 CST-Astellas Canadian Transplant Fellows Symposium. EBV Post Transplantation Implications and Approach to Management
2017 CST-Astellas Canadian Transplant Fellows Symposium EBV Post Transplantation Implications and Approach to Management Atul Humar, MD Atul Humar is a Professor in the Department of Medicine, University
More informationEBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases
Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause
More information